Skip to main content
Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic.
Subcortical grey matter volumes predict subsequent walking function in early multiple sclerosis.
Gut microbiota composition and relapse risk in pediatric MS: A pilot study.
Patient centered decision making: use of conjoint analysis to determine risk-benefit trade-offs for preference sensitive treatment choices.
Mechanisms of CNS remyelination--the key to therapeutic advances.